Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts

Journal of Periodontal Research

Volumn 37, Issue 4, 2002, Pages 250-254

  Maizumi, Noriko ^a   Tamura, Yukiko ^a   Kanai, Hideaki ^a   Tsutsui, Takeki ^a  

^a NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

Cytocidal ettect; LD50, macrolides; Periodontal ligament cells

Indexed keywords

ALKALINE PHOSPHATASE; ANTIINFECTIVE AGENT; AZITHROMYCIN; CLARITHROMYCIN; COLLAGEN TYPE 1; DRUG DERIVATIVE; ERYTHROMYCIN; JOSAMYCIN; KITASAMYCIN DERIVATIVE; MESSENGER RNA; MIDECAMYCIN; MIOKAMYCIN; ROKITAMYCIN; ROXITHROMYCIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION; GENETICS; HUMAN; LD 50; PERIODONTAL LIGAMENT; STATISTICS; TIME;

ALKALINE PHOSPHATASE; ANTI-BACTERIAL AGENTS; APOPTOSIS; AZITHROMYCIN; CELL SURVIVAL; CELLS, CULTURED; CLARITHROMYCIN; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROMYCIN; FIBROBLASTS; GENE EXPRESSION; HUMANS; JOSAMYCIN; LETHAL DOSE 50; LEUCOMYCINS; MIOCAMYCIN; PERIODONTAL LIGAMENT; RNA, MESSENGER; ROXITHROMYCIN; STATISTICS; TIME FACTORS;

EID: 0036691383     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0765.2002.01616.x     Document Type: Review

References (16)

1. Mashimo PA, Yamamoto Y, Slots J, Evens RT, Genco RJ. In vitro evaluation of antibiotics in the treatment of periodontal disease Pharmacol Ther Dent 1981, 6: 45-56.
2. Ishikawa I, Umeda M, Laosrisin N Clinical, bacteriological, and immunological examinations and the treatment process of two Papillon-Lefevre syndrome patients. J Periodontol 1994; 65: 364-371.
3. Barone A, Sbordone L, Ramaglia L. Ciaglia RN. Microbiotica associated with refractory periodontis. Prevalence and antibiotic susceptibility. Minerva Stomatol 1999, 48: 191-201.
4. Miyake Y, Tsuruda K, Okuda K, Widowati, Iwamoto Y, Suginaka H In vitro activity of tetracyclines, macrolides. quinolines, clindamycin and metronidazole against periodontopathic bacteria. J Periodont Res 1995; 30: 290-293.
5. Omori N, Kobayashi H, Tsutsui T. Quantitative comparison of cytocidal effects of tetracyclines and fluoroquinolones on human periodontal ligament fibroblasts. J Periodoni Res 1999; 34: 290-295.
6. Someya T, Tamura Y, Tsutsui T. Cytological and cytogenetic effects of the fluoroquinolone ofloxacin on human periodontal ligament fibroblasts. J Periodont Res 2000; 35: 352-360
7. Goldstein EJC, Citron DM, Merrian CV, Warren Y, Tyrrell K. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes, Antimicrob Agents Chemother 1999; 43: 2801-2805.
8. Piccolomini R, Catamo G. DiBonaventura G. Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitanis. Annmicrob Agents Chemother 1998; 42: 3000-3001
9. Piccolomini R, Di Bonaventura G. Catamo G, Picciani C, Paolantonio M In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin. Oral Microbial Immunol 1997; 12: 366-371.
10. Pajukanta R, Asikainen S, Saarela M, Alaluusua S, Jousimies-Somer H. In vitro activity of azithromycin compared with that of erythromycin against Actinobaciilus actinomycetemcomitans. Antimicrob Agents Chemother 1992; 36: 1241-1243.
11. Agen C, Danesi R, Blandizzi C et al. Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role. Agents Actions 1993, 38: 85-90
12. Oishi K, Sonoda F, Kobayashi S et al. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chroinc airway diseases Infect Immun 1994; 62: 4145-4152.
13. Markham A, Faulds D. Roxithromycin: An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use. Drugs 1994; 48: 297-326
14. Yoshii T, Hamamoto Y, Muraoka S et al. Clinical study on long-term macrolide treatment for diffuse sclerosing mandibular osteomyelitis - long-term follow up using roxithromycin. J Jpn Stomatol Soc 1999, 48: 479-488.
15. Kurita H, Kurashina K, Kotani A. Use of low dose roxithromycin in management of chronic periodontal disease - clinical efficacy and effect on phagocytosis and intracellular killing of polymorphonuclear leukocytes,. Oral Ther Pharmacol 1997; 16: 110-114.
16. Kapusnik-Uner JE, Sande MA et al Macrolides (erythromycin, clarithromycin. and azithromycin). In: Hardman, JG, Limbird, LE, Molinoff, PB, Ruddon, RW, Oilman. AG, eds. Goodman and Gilman's The pharmacological basis of therapeutics. New York: Macmillan Publishing, 1996: 1135-1140.